HF
GCTK icon

HRT Financial’s GlucoTrack GCTK Stock Holding History

HRT Financial’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Buy
205,442
+164,811
+406% +$103K ﹤0.01% 3714
2026
Q1 		$26K Buy
+40,631
New +$86.3K ﹤0.01% 3542
2025
Q2 		– Sell
-587
Closed -$6K – 2957
2025
Q1 		$6K Buy
+587
New +$39.4K ﹤0.01% 2391

Other funds holding GCTK

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.29B AUM 30.87% 1-Year Est. Return

HRT Financial's GCTK Position: Q2 2026 in Review

HRT Financial increased its GlucoTrack (GCTK) stake by 406% in Q2 2026, buying an estimated $103K and bringing the position to 205,442 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #3714.

HRT Financial first reported a position in GCTK in Q1 2025 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • HRT Financial held 205,442 shares of GlucoTrack worth $65K as of Q2 2026.
  • HRT Financial bought 164,811 GlucoTrack shares in Q2 2026, an estimated $103K.
  • GlucoTrack made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3714 holding.
  • HRT Financial first reported a position in GlucoTrack in Q1 2025 and has held it in 3 quarters since.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.